Bortezomib Ocular Toxicities: Outcomes With Ketotifen

American Journal of Hematology - United States
doi 10.1002/ajh.25382
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Erratum: Ocular Toxicities Associated With Targeted Anticancer Agents: An Analysis of Clinical Data With Management Suggestions

Oncotarget
Oncology
2019English

Treatment Outcomes and Late Toxicities in Patients With Embryonal Central Nervous System Tumors

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Ketotifen Treatment of Nasal Allergy.

Practica Otologica
Otorhinolaryngology
1986English

The Relations of Dosimetric Parameters With Long‐term Outcomes and Late Toxicities in Advanced T‐stage Nasopharyngeal Carcinoma With IMRT

Head and Neck
Otorhinolaryngology
2019English

Ocular Adnexal Diffuse Large B-Cell Lymphoma: Local Disease Correlates With Better Outcomes

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL Amyloidosis Treated With Bortezomib

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Management of Dermatologic Toxicities Associated With Targeted Therapy

Journal of the Advanced Practitioner in Oncology
2016English

Managing Pulmonary Toxicities Associated With Immunotherapy: A Case Discussion

Oncologist
Cancer ResearchMedicineOncology
2019English

Periodic Fever Syndrome With Aphthous Stomatitis, Pharyngitis and Cervical Adenopathy Treated With Ketotifen � a Case Report

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy